Advertisement
Research Article

Heterokaryon-Based Reprogramming of Human B Lymphocytes for Pluripotency Requires Oct4 but Not Sox2

  • Carlos F. Pereira,

    Affiliation: Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

    X
  • Rémi Terranova,

    Affiliation: Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

    Current address: Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland

    X
  • Natalie K. Ryan,

    Affiliation: Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

    X
  • Joana Santos,

    Affiliation: Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

    X
  • Kelly J. Morris,

    Affiliation: Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

    X
  • Wei Cui,

    Affiliation: Stem Cell Initiative, Institute of Reproductive and Developmental Biology, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom

    X
  • Matthias Merkenschlager,

    Affiliation: Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

    X
  • Amanda G. Fisher mail

    amanda.fisher@csc.mrc.ac.uk

    Affiliation: Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

    X
  • Published: September 05, 2008
  • DOI: 10.1371/journal.pgen.1000170

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.